TomoTherapy(R) Cancer Treatment Technology Debuts in Switzerland
13 12월 2007 - 6:42AM
Business Wire
TomoTherapy Incorporated (NASDAQ: TTPY) announced today that the
University Hospital of Lausanne (CHUV) has begun treating patients
with the TomoTherapy� Hi-Art��treatment system, the first to be
installed in Switzerland. �We are pleased to work with the CHUV to
make this new weapon in the fight against cancer available to Swiss
patients,� said Rik Van den Neste, M.D., director of European sales
for TomoTherapy. �By implementing the TomoTherapy platform, the
CHUV demonstrates its leadership and commitment to providing access
to new strategies for care.� The CHUV ranks 14th among 400
institutions affiliated with the European Organisation for Research
and Treatment of Cancer (EORTC), which aims to reduce the time
lapse between the discovery of new technologies and the
implementation of their therapeutic benefit for patients with
cancer. The Hospital provides holistic care for a wide range of
cancer patients and looks forward to strengthening this approach
with the unique capabilities of the Hi-Art treatment system. Said
Professor Ren�-Olivier Mirimanoff, M.D., head of the Radio-Oncology
department, �TomoTherapy helps us better target the tumour to be
irradiated and preserve healthy tissue located in the vicinity.
Integrated CT imaging allows for the scanning of patients before
each treatment, which helps ensure proper positioning.� Dr Rapha�l
Moeckli, Ph.D., head physicist, added, �The system�s delivery
pattern makes it possible to �paint� the dose onto the tumour
volume, from 360 degrees. These features open new possibilities for
minimizing the side effects of treatment, and for treating types of
cancer that were previously difficult to irradiate because of
nearby critical structures.� The Radio-Oncology Department, managed
by the CHUV, recently hosted a ceremony to introduce this
state-of-the-art technology that integrates CT image guidance and
helical intensity-modulated radiation therapy for greater accuracy
and precision in the treatment of cancer. The event included a
scientific symposium attended by radiation oncologists, medical
physicists and therapists from across Switzerland and a public
conference attended by more than 100 local journalists and patient
group members. About the CHUV CHUV is one of the 5 major university
hospitals in Switzerland. It provides from primary to tertiary care
in all domains of medicine, and one of its major focuses is cancer.
Many doctors and scientists are involved in basic, translational
and clinical research in cancer medicine, which contributes to its
international visibility. A number of clinicians are currently
involved in national and international cooperative cancer research
groups, including SAKK, EORTC, and hold officer�s positions or have
a leading role as principal investigators of international trials.
The department of Radiation Oncology has an active role and has
contributed to a number of major international studies in various
fields of oncology and has a leading position in Switzerland About
TomoTherapy Incorporated TomoTherapy Incorporated has developed,
manufactures and sells the TomoTherapy� Hi-Art� treatment system,
an advanced radiation therapy system for the treatment of a wide
variety of cancers. The Hi-Art treatment system combines integrated
CT imaging with conformal radiation therapy to deliver
sophisticated radiation treatments with speed and precision while
reducing radiation exposure to surrounding healthy tissue. The
company completed its initial public offering in May 2007 and its
stock is traded on the NASDAQ Global Market under the symbol TTPY.
To learn more about TomoTherapy, please visit our Web site at
www.TomoTherapy.com. �2007 TomoTherapy Incorporated. All rights
reserved.�TomoTherapy, the TomoTherapy logo and Hi-Art are among
trademarks, service marks or registered trademarks of TomoTherapy
Incorporated.
Tomotherapy Incorporated (MM) (NASDAQ:TTPY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tomotherapy Incorporated (MM) (NASDAQ:TTPY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Tomotherapy Incorporated (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More TomoTherapy Incorporated News Articles